XNAS · BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES) · BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
Includes notes from domestic 8-K and foreign private issuer 6-K disclosures.
Gilead Sciences (GILD) had 2 Form 144 pre-sale notices filed on 2026-06-15. Form 144 filings signal an insider's intent to sell securities under SEC Rule 144 — they do not confirm a completed transaction. At least one fi…
Gilead Sciences (GILD) had 1 Form 144 pre-sale notice filed on 2026-06-01. Form 144 filings signal an insider's intent to sell securities under SEC Rule 144 — they do not confirm a completed transaction. At least one fil…
Gilead Sciences (GILD) had 2 Form 144 pre-sale notices filed on 2026-05-15. Form 144 filings signal an insider's intent to sell securities under SEC Rule 144 — they do not confirm a completed transaction. At least one fi…
TL;DR: Gilead Sciences reported Q1 2026 EPS of $1.61, up 54.8% from $1.04 a year ago, on total revenues of $7.0 billion. The company immediately raised its full-year revenue guidance, signaling management's confidence th…
Gilead Sciences (GILD) had 3 Form 144 pre-sale notices filed between 2026-04-15 and 2026-04-28. Form 144 filings signal an insider's intent to sell securities under SEC Rule 144 — they do not confirm a completed transact…
Gilead Sciences Inc (GILD) had 3 Form 144 pre-sale notices filed between 2026-04-15 and 2026-04-28. Form 144 filings signal an insider's intent to sell securities under SEC Rule 144 — they do not confirm a completed tran…
| Date | Insider | Title | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 6/15/2026 | Dickinson Andrew D | Chief Financial Officer | SELL | -3,000 | $125 | $376,200 |
| 6/15/2026 | Mercier Johanna | Chief Comm & Corp Aff Officer | SELL | -450 | $125 | $56,430 |
| 6/15/2026 | Mercier Johanna | Chief Comm & Corp Aff Officer | SELL | -1,070 | $124 | $132,676 |
| 6/15/2026 | Mercier Johanna | Chief Comm & Corp Aff Officer | SELL | -1,480 | $123 | $182,657 |
| 6/10/2026 | O'Day Daniel Patrick | Chairman & CEO | OPTION_EXERCISE | -8,779 | — | — |
| 6/10/2026 | O'Day Daniel Patrick | Chairman & CEO | TAX_WITHHOLD | -4,213 | $121 | $511,795 |
| 6/10/2026 | O'Day Daniel Patrick | Chairman & CEO | OPTION_EXERCISE | 8,779 | — | — |
| 6/10/2026 | Mercier Johanna | Chief Comm & Corp Aff Officer | OPTION_EXERCISE | -2,796 | — | — |
| 6/10/2026 | Mercier Johanna | Chief Comm & Corp Aff Officer | TAX_WITHHOLD | -1,341 | $121 | $162,905 |
| 6/10/2026 | Mercier Johanna | Chief Comm & Corp Aff Officer | OPTION_EXERCISE | 2,796 | — | — |
| 6/10/2026 | Dickinson Andrew D | Chief Financial Officer | OPTION_EXERCISE | -2,796 | — | — |
| 6/10/2026 | Dickinson Andrew D | Chief Financial Officer | TAX_WITHHOLD | -1,341 | $121 | $162,905 |
| 6/10/2026 | Dickinson Andrew D | Chief Financial Officer | OPTION_EXERCISE | 2,796 | — | — |
| 6/10/2026 | Berger Dietmar | Chief Medical Officer | OPTION_EXERCISE | -533 | — | — |
| 6/10/2026 | Berger Dietmar | Chief Medical Officer | TAX_WITHHOLD | -263 | $121 | $31,949 |
| 6/10/2026 | Berger Dietmar | Chief Medical Officer | OPTION_EXERCISE | 533 | — | — |
| 6/10/2026 | Cain Wettan Keeley M | EVP Gen Counsel, Legal & Comp | OPTION_EXERCISE | -589 | — | — |
| 6/10/2026 | Cain Wettan Keeley M | EVP Gen Counsel, Legal & Comp | TAX_WITHHOLD | -283 | $121 | $34,379 |
| 6/10/2026 | Cain Wettan Keeley M | EVP Gen Counsel, Legal & Comp | OPTION_EXERCISE | 589 | — | — |
| 6/1/2026 | O'Day Daniel Patrick | Chairman & CEO | SELL | -1,038 | $133 | $138,021 |
| Date | Filer | Relationship | Est. shares | Filing |
|---|---|---|---|---|
| 6/15/2026 | JOHANNA MERCIER | — | 3,000 | SEC |
| 6/15/2026 | ANDREW DICKINSON | — | 3,000 | SEC |
| 6/1/2026 | DANIEL O'DAY | — | 35,000 | SEC |
| 5/15/2026 | ANDREW DICKINSON | — | 3,000 | SEC |
| 5/15/2026 | JOHANNA MERCIER | — | 28,000 | SEC |
| 4/28/2026 | DANIEL O'DAY | — | — | SEC |
| 4/15/2026 | JOHANNA MERCIER | — | 3,000 | SEC |
| 4/15/2026 | ANDREW DICKINSON | — | 3,000 | SEC |
| Institution | Shares | Value ($) | Change % | Filing date |
|---|---|---|---|---|
| Vanguard Group | 121,097,336 | $14,863,487,020 | — | 1/29/2026 |
| BlackRock | 120,632,023 | $8,276,563,065 | — | 8/13/2024 |
| Fidelity (FMR) | 65,579,490 | $8,049,226,574 | — | 2/17/2026 |
| State Street | 60,240,518 | $7,393,921,179 | — | 2/13/2026 |
| JP Morgan Chase | 23,871,863 | $2,930,032,699 | — | 2/11/2026 |
| Citadel Advisors | 6,057,220 | $743,463,183 | — | 2/17/2026 |
| AQR Capital | 2,694,944 | $330,777,425 | — | 2/17/2026 |
| Millennium Management | 971,219 | $119,207,420 | — | 2/17/2026 |
| DE Shaw | 300,405 | $36,871,710 | — | 2/17/2026 |
| Bridgewater Associates | 292,406 | $35,889,912 | — | 2/13/2026 |
| Point72 | 59,600 | $7,315,304 | — | 2/17/2026 |
| Two Sigma | 11,100 | $1,362,414 | — | 2/17/2026 |